GOLDFARB ROBERT I (Chief Operating Officer) received a stock award from NEXIEN BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/14/2022ACC: 0001214659-22-011127
Officer· Chief Operating Officer
Since Aug 2018
+1.25M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.25M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+250K
Price / share
—
Trade value
—
% of position
24.3%
7/27/2022
1.03M→1.28M
Total
Net shares
+250K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/27/2022 | A · Award | +250K | — | — | 24.3% | 1.03M | 1.28M |
| Total | +250K | $0.00 | ||||||
Derivative Transactions1
Options to purchase common stock (right to buy)
Direct
Converts to
Common Stock
1M shares
Shares
+1M
Strike price
0.08
Held after
1M
Exercisable
—
8/19/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Options to purchase common stock (right to buy) Direct | Common Stock1M shares | 8/19/2020 | A · Award | +1M | 0.08 | — | 1M |